Callan JMB CEO, Wayne Williams Invited to Attend the 50th International GMP Conference on March 2-5, 2026

Callan JMB Inc. (NASDAQ: CJMB), a leading integrative logistics company specializing in healthcare and emergency management, proudly announces that its CEO, Wayne Williams, has been invited to the 50th International GMP Conference, scheduled for March 2-5, 2026, in Athens, Georgia. Co-sponsored by the University of Georgia College of Pharmacy and the U.S. Food & Drug Administration (FDA), this prestigious event has been a significant annual gathering since 1976, serving as a platform for regulatory authorities, industry leaders, and professionals to engage in discussions about evolving ideas within the pharmaceutical and regulatory landscapes.

Wayne Williams expressed his enthusiasm about attending the conference, emphasizing the importance of remaining at the forefront of advancements in healthcare logistics and emergency preparedness amidst rapid technological changes and regulatory developments. He noted, "It's an honor to attend this prestigious conference... I look forward to contributing to the dialogue and bringing back insights that further our mission to ensure the safety and integrity of essential products through technology-enabled, efficient distribution."

Founded with a commitment to supporting the healthcare sector, Callan JMB Inc. offers comprehensive logistics services that include fulfillment, storage, monitoring, and advanced cold chain logistics. The company aims to secure medical materials, ensuring compliance and safety for patients and communities. With unmatched expertise in supply chain logistics, thermodynamics, biologics, and regulatory compliance, Callan JMB positions itself as a leader in the industry, dedicated to delivering a gold standard client experience through innovative solutions.

For further details about the International GMP Conference, interested parties can visit https://internationalgmp.com/.

As Callan JMB Inc. prepares for its participation in the prestigious 50th International GMP Conference, scheduled for March 2-5, 2026, it presents an opportunity for investors to assess the company's trajectory within the burgeoning healthcare logistics sector. With Wayne Williams, CEO and founder, attending this globally recognized event, Callan JMB positions itself to leverage insights from industry leaders that could steer strategic initiatives moving forward.

Callan JMB operates at the critical intersection of supply chain logistics and healthcare, providing essential services including fulfillment, storage, and cold chain logistics. The upcoming conference, in collaboration with the University of Georgia College of Pharmacy and the U.S. FDA, focuses on addressing regulatory developments and technological advancements that are pivotal to the pharmaceutical industry. Given the rapid evolution in healthcare logistics, Callan's attendance is timely as the company aims to enhance its operational capabilities amid changing regulations and emerging technologies.

This strategic presence at an influential gathering underlines Callan JMB's commitment to remaining proactive in a competitive market. Investors should take note of the emphasis on emergency preparedness and compliance, key areas that not only safeguard public health but also enhance the company’s reputation and reliability—a critical component when securing new contracts and partnerships.

Moreover, as healthcare systems evolve towards increased sustainability and efficiency, Callan JMB's focus on customizable interfaces and environmentally friendly practices can position it favorably against competitors that may not prioritize these values. Therefore, potential investors should observe how insights gained from the GMP Conference are integrated into the company's strategies. A keen eye on these developments could yield insights into Callan JMB's long-term growth trajectory, making it a compelling prospect in the healthcare logistics market.